Moderna exec tells of company’s pursuit of COVID vaccine
Moderna didn’t expect to go to market with its new vaccine technology for several years when 2020 began, the company’s CFO said in a recent talk, but that changed after the technology Moderna spent almost a decade developing helped fast-forward development for COVID-19 vaccines. More than 1,000 people watched a virtual discussion on Feb. 17 Read More →
Read More →Lack of masks, insufficient translations: Farmworkers tell of COVID response problems
For months, many farmworkers in the tri-county region and the rest of California, especially indigenous workers who speak neither Spanish nor English, were not properly informed of the dangers of COVID-19, leading to outbreaks and poor working conditions. Despite being labeled essential workers by the state, farmworkers often felt ignored, according to a recent study Read More →
Read More →Chamber releases new plan for reopening, recovery
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Opinion: A guide to state programs to stop the spread of COVID in the workplace
By Kim L. Hunter It’s difficult to try to understand how much the world has changed in just one short year. What started off as sheltering in place, attempting to master the art of baking sourdough bread from scratch, soon turned into unprecedented loss in every sense of the word. From loss of life to Read More →
Read More →UCLA opens cancer clinic in Santa Barbara
UCLA Health has opened a new cancer care clinic near Cottage Hospital in Santa Barbara. The new clinic, at 309 W. Quinto St., will expand treatment options for residents of Santa Barbara and the surrounding areas, as they will be able to get regular treatment and participate in more than 600 UCLA cancer clinical trials Read More →
Read More →Amgen shares slip after projections of flat 2021 sales
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Arcutis stock soars on drug trial news; company announces $150M capital raise
Stock of Arcutis Biotherapeutics, a Westlake Village-based company developing dermatological treatments, shot up more than 30% on Feb. 1 after the company released positive results from a recent clinical trial. Later in the day, Arcutis said it plans to sell $150 million worth of its common stock. Before stock trading opened, the company announced positive Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
